Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response

Affiliations

• ¹ Oslo University Hospital, Section for Clinical Immunology and Infectious Diseases, Norway.
• ² ANRS, Clinical Research Safety Department, France; INSERM, Clinical Research Safety Department, France.
• ³ Erasmus Hospital, Infectious Diseases, Belgium.
• ⁴ Norwegian Institute of Public Health, Division of Infectious Disease Control, Norway.
• ⁵ INSERM, IAME, Hôpital Bichat - Claude-Bernard, Infectious Diseases Department, France. Electronic address: yazdan.yazdanpanah@inserm.fr.